日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Differentiating iron-loading anemias using a newly developed and analytically validated ELISA for human serum erythroferrone

利用新开发并经分析验证的人血清红细胞生成素ELISA方法鉴别铁过载性贫血

Diepeveen, Laura; Roelofs, Rian; Grebenchtchikov, Nicolai; van Swelm, Rachel; Kautz, Leon; Swinkels, Dorine

Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer

磷酸丝氨酸氨基转移酶1与复发性乳腺癌患者接受他莫昔芬治疗的不良预后相关

De Marchi, Tommaso; Timmermans, Mieke A; Sieuwerts, Anieta M; Smid, Marcel; Look, Maxime P; Grebenchtchikov, Nicolai; Sweep, Fred C G J; Smits, Jan G; Magdolen, Viktor; van Deurzen, Carolien H M; Foekens, John A; Umar, Arzu; Martens, John W

Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells

激肽释放酶相关肽酶 4:结肠癌细胞中异常表达的蛋白酶激活受体 1 的新型激活剂

Gratio, Valérie; Beaufort, Nathalie; Seiz, Lina; Maier, Josefine; Virca, G Duke; Debela, Mekdes; Grebenchtchikov, Nicolai; Magdolen, Viktor; Darmoul, Dalila

Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours

尿激酶型纤溶酶原激活物受体(uPAR)在原发性乳腺肿瘤细胞溶胶和沉淀提取物中的预后影响

de Witte, J H; Foekens, J A; Brünner, N; Heuvel, J J; van Tienoven, T; Look, M P; Klijn, J G; Geurts-Moespot, A; Grebenchtchikov, N; Benraad, T; Sweep, C G